DK0906907T3 - Forbindelser, der potenserer retinoid - Google Patents
Forbindelser, der potenserer retinoidInfo
- Publication number
- DK0906907T3 DK0906907T3 DK96931263T DK96931263T DK0906907T3 DK 0906907 T3 DK0906907 T3 DK 0906907T3 DK 96931263 T DK96931263 T DK 96931263T DK 96931263 T DK96931263 T DK 96931263T DK 0906907 T3 DK0906907 T3 DK 0906907T3
- Authority
- DK
- Denmark
- Prior art keywords
- hydrogen atom
- alkyl group
- represents hydrogen
- group
- retinoid
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
- C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
- C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
- C07D243/38—[b, e]- or [b, f]-condensed with six-membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
- C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
- C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
- C07D243/14—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
- C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
- C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
- C07D243/14—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
- C07D243/16—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals
- C07D243/18—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals substituted in position 2 by nitrogen, oxygen or sulfur atoms
- C07D243/24—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D267/00—Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D267/02—Seven-membered rings
- C07D267/08—Seven-membered rings having the hetero atoms in positions 1 and 4
- C07D267/12—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
- C07D267/14—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems condensed with one six-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D267/00—Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D267/02—Seven-membered rings
- C07D267/08—Seven-membered rings having the hetero atoms in positions 1 and 4
- C07D267/12—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
- C07D267/16—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems condensed with two six-membered rings
- C07D267/20—[b, f]-condensed
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D281/00—Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one sulfur atom as the only ring hetero atoms
- C07D281/02—Seven-membered rings
- C07D281/04—Seven-membered rings having the hetero atoms in positions 1 and 4
- C07D281/08—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
- C07D281/10—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems condensed with one six-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D281/00—Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one sulfur atom as the only ring hetero atoms
- C07D281/02—Seven-membered rings
- C07D281/04—Seven-membered rings having the hetero atoms in positions 1 and 4
- C07D281/08—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
- C07D281/12—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems condensed with two six-membered rings
- C07D281/16—[b, f]-condensed
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP24263995 | 1995-09-21 | ||
JP15058296 | 1996-06-12 | ||
PCT/JP1996/002709 WO1997011061A1 (fr) | 1995-09-21 | 1996-09-20 | Composes a potentialisation de retinoide |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0906907T3 true DK0906907T3 (da) | 2002-04-22 |
Family
ID=26480129
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK96931263T DK0906907T3 (da) | 1995-09-21 | 1996-09-20 | Forbindelser, der potenserer retinoid |
Country Status (13)
Country | Link |
---|---|
US (3) | US5929069A (da) |
EP (1) | EP0906907B1 (da) |
KR (1) | KR100484294B1 (da) |
CN (1) | CN1121395C (da) |
AT (1) | ATE214055T1 (da) |
AU (1) | AU7001596A (da) |
CA (1) | CA2233012A1 (da) |
DE (1) | DE69619711T2 (da) |
DK (1) | DK0906907T3 (da) |
EA (1) | EA002123B1 (da) |
NO (1) | NO981269L (da) |
TW (1) | TW420667B (da) |
WO (1) | WO1997011061A1 (da) |
Families Citing this family (40)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000066106A2 (en) | 1999-04-30 | 2000-11-09 | The Regents Of The University Of Michigan | Use of benzodiazepines for treating autoimmune diseases induced by apoptosis |
WO1997011061A1 (fr) * | 1995-09-21 | 1997-03-27 | Nikken Chemicals Co., Ltd. | Composes a potentialisation de retinoide |
EP1048659A4 (en) * | 1997-11-12 | 2002-11-20 | Inst Med Molecular Design Inc | RETINOID RECEPTOR AGONISTS |
JP4204657B2 (ja) * | 1997-12-05 | 2009-01-07 | 有限会社ケムフィズ | 糖尿病の予防・治療剤 |
US6083973A (en) * | 1998-03-09 | 2000-07-04 | Syntex (U.S.A.) Inc. | Methods for inhibiting mucin secretion using RAR α selective antagonists |
JP4693247B2 (ja) | 1999-04-28 | 2011-06-01 | 有限会社ケムフィズ | 複素環カルボン酸誘導体 |
US20060025388A1 (en) | 1999-04-30 | 2006-02-02 | Glick Gary D | Compositions and methods relating to novel compounds and targets thereof |
US7572788B2 (en) | 1999-04-30 | 2009-08-11 | The Regents Of The University Of Michigan | Compositions and methods relating to novel compounds and targets thereof |
WO2004083413A1 (ja) | 2003-03-20 | 2004-09-30 | Research Foundation Itsuu Laboratory | 器官形成方法 |
GB0308335D0 (en) | 2003-04-10 | 2003-05-14 | Novartis Ag | Organic compounds |
KR20070007818A (ko) | 2004-03-10 | 2007-01-16 | 재단법인 이쯔우 연구소 | 기억 고정 촉진제 |
WO2005099759A1 (ja) * | 2004-04-16 | 2005-10-27 | Institute Of Medicinal Molecular Design. Inc. | 動脈硬化症の予防及び/又は治療のための医薬 |
EP1893218A4 (en) | 2005-06-01 | 2011-01-12 | Univ Michigan | NON-SOLVATED BENZODIAZEPINE PREPARATIONS AND METHODS |
EP2286807A3 (en) * | 2005-09-09 | 2012-08-29 | Kemphys Ltd. | Medicament for preventive and/or therapeutic treatment of adhesion of bowel |
AU2006308655B2 (en) | 2005-11-01 | 2010-09-23 | The Regents Of The University Of Michigan | Novel 1,4-benzodiazepine-2,5-diones with therapeutic properties |
NZ573452A (en) | 2006-06-09 | 2011-09-30 | Univ Michigan | Compositions and methods relating to novel compounds and targets thereof |
JP2008081427A (ja) * | 2006-09-27 | 2008-04-10 | R&R Inc | 分泌障害性疾患の予防及び/又は治療のための医薬 |
US7902260B2 (en) * | 2007-02-28 | 2011-03-08 | Kemphys Ltd. | Medicament for preventive and/or therapeutic treatment of lower urinary tract symptom |
US7851465B2 (en) | 2007-03-09 | 2010-12-14 | The Regents Of The University Of Michigan | Compositions and methods relating to novel compounds and targets thereof |
JP5399249B2 (ja) | 2007-08-15 | 2014-01-29 | 財団法人乙卯研究所 | 3環系アミン化合物 |
ES2614498T3 (es) | 2007-09-14 | 2017-05-31 | The Regents Of The University Of Michigan | Inhibidores de ATPasa F1F0 y métodos relacionados |
BRPI0820477A2 (pt) | 2007-11-06 | 2015-06-16 | Univ Michigan | Compostos de benzodiazepinona úteis no tratamento de afecções da pele |
JP5567573B2 (ja) | 2008-09-11 | 2014-08-06 | ザ リージェンツ オブ ザ ユニバーシティ オブ ミシガン | アリールグアニジンf1f0−atpアーゼ阻害剤およびそれと関連する方法 |
US8604023B2 (en) | 2009-04-17 | 2013-12-10 | The Regents Of The University Of Michigan | 1,4-benzodiazepinone compounds and their use in treating cancer |
EP2470020A4 (en) | 2009-09-18 | 2013-03-13 | Univ Michigan | BENZODIAZEPINONE COMPOUNDS AND TREATMENT METHODS THEREWITH |
WO2011037128A1 (ja) | 2009-09-28 | 2011-03-31 | 日本曹達株式会社 | 含窒素ヘテロ環化合物およびその塩ならびに農園芸用殺菌剤 |
CA2780287C (en) | 2009-11-17 | 2015-03-17 | The Regents Of The University Of Michigan | 1,4-benzodiazepine-2,5-diones and related compounds with therapeutic properties |
US9126978B2 (en) | 2009-11-17 | 2015-09-08 | The Regents Of The University Of Michigan | 1,4-benzodiazepine-2,5-diones and related compounds with therapeutic properties |
AR084070A1 (es) | 2010-12-02 | 2013-04-17 | Constellation Pharmaceuticals Inc | Inhibidores del bromodominio y usos de los mismos |
WO2012075456A1 (en) | 2010-12-02 | 2012-06-07 | Constellation Pharmaceuticals | Bromodomain inhibitors and uses thereof |
WO2012112623A2 (en) * | 2011-02-14 | 2012-08-23 | Sloan-Kettering Institute For Cancer Research | Rxrg modulators for the treatment of cancer |
WO2012151512A2 (en) | 2011-05-04 | 2012-11-08 | Constellation Pharmaceuticals, Inc. | Bromodomain inhibitors and uses thereof |
EP2721031B1 (en) | 2011-06-17 | 2016-01-20 | Constellation Pharmaceuticals, Inc. | Bromodomain inhibitors and uses thereof |
EP2864336B1 (en) | 2012-06-06 | 2016-11-23 | Constellation Pharmaceuticals, Inc. | Benzo[b]isoxazoloazepine bromodomain inhibitors and uses thereof |
TWI602820B (zh) | 2012-06-06 | 2017-10-21 | 星宿藥物公司 | 溴域抑制劑及其用途 |
CN103304494B (zh) * | 2013-06-20 | 2015-05-27 | 河北大学 | 茚(1,2-b)喹喔啉-11-酮肟衍生物及其制备方法和用途 |
CA2952830C (en) | 2014-06-20 | 2022-11-01 | Constellation Pharmaceuticals, Inc. | Crystalline forms of 2-((4s)-6-(4-chlorophenyl)-1-methyl-4h-benzo[c]isoxazolo[4,5-e]azepin-4-yl)acetamide |
KR200489267Y1 (ko) | 2018-09-20 | 2019-05-23 | 김은진 | 폭 조절형 옷걸이 |
KR200490993Y1 (ko) | 2019-06-14 | 2020-02-04 | 이현봉 | 구김방지기능을 구비한 바지걸이 |
CN114702454A (zh) * | 2022-03-29 | 2022-07-05 | 江西师范大学 | 5-烷基-11-芳基-5H-二苯并[b,e][1,4]二氮杂卓衍生物的制备方法 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH04211071A (ja) * | 1990-03-05 | 1992-08-03 | Hokuriku Seiyaku Co Ltd | 多環式化合物 |
WO1997011061A1 (fr) * | 1995-09-21 | 1997-03-27 | Nikken Chemicals Co., Ltd. | Composes a potentialisation de retinoide |
JP4204657B2 (ja) * | 1997-12-05 | 2009-01-07 | 有限会社ケムフィズ | 糖尿病の予防・治療剤 |
-
1996
- 1996-09-20 WO PCT/JP1996/002709 patent/WO1997011061A1/ja active IP Right Grant
- 1996-09-20 DK DK96931263T patent/DK0906907T3/da active
- 1996-09-20 CN CN96198386A patent/CN1121395C/zh not_active Expired - Fee Related
- 1996-09-20 AU AU70015/96A patent/AU7001596A/en not_active Abandoned
- 1996-09-20 KR KR10-1998-0702114A patent/KR100484294B1/ko not_active IP Right Cessation
- 1996-09-20 TW TW085111550A patent/TW420667B/zh not_active IP Right Cessation
- 1996-09-20 EP EP96931263A patent/EP0906907B1/en not_active Expired - Lifetime
- 1996-09-20 US US08/710,657 patent/US5929069A/en not_active Expired - Lifetime
- 1996-09-20 DE DE69619711T patent/DE69619711T2/de not_active Expired - Lifetime
- 1996-09-20 CA CA002233012A patent/CA2233012A1/en not_active Abandoned
- 1996-09-20 AT AT96931263T patent/ATE214055T1/de not_active IP Right Cessation
- 1996-09-20 EA EA199800318A patent/EA002123B1/ru not_active IP Right Cessation
-
1998
- 1998-03-20 NO NO981269A patent/NO981269L/no unknown
-
1999
- 1999-04-09 US US09/288,618 patent/US6121256A/en not_active Expired - Fee Related
-
2001
- 2001-04-20 US US09/838,272 patent/US6476017B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CN1121395C (zh) | 2003-09-17 |
EP0906907B1 (en) | 2002-03-06 |
CN1202160A (zh) | 1998-12-16 |
KR100484294B1 (ko) | 2005-09-09 |
EP0906907A1 (en) | 1999-04-07 |
ATE214055T1 (de) | 2002-03-15 |
EA199800318A1 (ru) | 1998-10-29 |
US5929069A (en) | 1999-07-27 |
KR19990063661A (ko) | 1999-07-26 |
AU7001596A (en) | 1997-04-09 |
US20010039272A1 (en) | 2001-11-08 |
DE69619711D1 (de) | 2002-04-11 |
DE69619711T2 (de) | 2002-10-17 |
NO981269L (no) | 1998-05-20 |
EA002123B1 (ru) | 2001-12-24 |
US6121256A (en) | 2000-09-19 |
CA2233012A1 (en) | 1997-03-27 |
US6476017B2 (en) | 2002-11-05 |
NO981269D0 (no) | 1998-03-20 |
WO1997011061A1 (fr) | 1997-03-27 |
EP0906907A4 (da) | 1999-04-07 |
TW420667B (en) | 2001-02-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK0906907T3 (da) | Forbindelser, der potenserer retinoid | |
PL334915A1 (en) | Pyrrolidine derivatives exhibiting phospholipase a2 inhibiting activity | |
NO20002169D0 (no) | Nye pyridazinderivater og medikamenter inneholdende disse som effektive ingredienser | |
DK0807630T3 (da) | Heterocykliske forbindelser | |
ATE204576T1 (de) | Methotrexat-derivate | |
FI943508A (fi) | Pyridiinikarboksimidamidiyhdisteet ja niiden käyttö | |
ES8702343A1 (es) | Un procedimiento para la produccion de un derivado de diami-das de n-acilaminoacidos | |
DE69326479T2 (de) | Methotrexat-derivate | |
ATE168679T1 (de) | Neue tetracyclische verbindungen | |
ATE119891T1 (de) | Benzothiazol-derivate als fungizide. | |
ES2067388A1 (es) | Procedimiento para la produccion de derivados de piroglutamato de configuracion 2,4-cis |